Longitudinal (2001–14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010–13) analysis of oritavancin in vitro potency
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.